ProShares Expands Largest Lineup of Leveraged and Inverse ETFs

ProShares, a premier provider of alternative ETFs, today announced the launch of six new geared ETFs. The new ETFs offer leveraged and inverse exposure to the biotechnology, homebuilding, and oil and gas exploration and production sectors.

“The ETFs we are launching today offer knowledgeable investors new ways to obtain magnified and inverse exposure to widely followed U.S. sectors,” said Michael L. Sapir, co-founder and CEO of ProShare Advisors LLC, the advisor to ProShares. “As the world’s leader in leveraged and inverse ETFs, we are committed to giving investors more choices to manage risk and pursue returns.”

Each new ProShares ETF seeks to provide a multiple of the daily performance of an index, before fees and expenses, as noted below:

About the Indexes

The NASDAQ Biotechnology Index is a modified capitalization weighted index that includes NASDAQ Stock Market listed companies that are classified as either biotechnology or pharmaceutical.

The Dow Jones U.S. Select Home Construction Index includes U.S. companies whose business is related to the construction of residential homes, including manufacturers of mobile and prefabricated homes, as well as producers, sellers and suppliers of building materials, furnishings and fixtures.

The S&P Oil & Gas Exploration & Production Select Industry Index is equally weighted and includes domestic companies from the oil and gas exploration and production sub-industry.

About ProShares

ProShares offers the nation's largest lineup of alternative ETFs. We help investors to go beyond the limitations of conventional investing and face today's market challenges. ProShares helps investors build better portfolios by providing access to alternative investments delivered with the liquidity, transparency and cost effectiveness of ETFs. Our wide array of alternative ETFs can help you reduce volatility, manage risk and enhance returns.

ProShares is the world’s largest provider of geared exchange traded products according to Lipper, based on a worldwide analysis of all known providers of funds in these categories. The analysis covered ETFs and ETNs by assets and number of funds (as of 12/31/2014).

ProShares has the largest lineup of alternative ETFs in the United States according to Strategic Insight, based on analysis of all the known alternative ETF providers (as defined by Strategic Insight) by their number of funds and assets (as of 1/31/2015).

These geared (Short or Ultra) ProShares ETFs seek returns that are either 3x, 2x, -2x or -3x the return of an index or other benchmark (target) for a single day, as measured from one NAV calculation to the next. Due to the compounding of daily returns, Geared ProShares’ returns over periods other than one day will likely differ in amount and possibly direction from the target return for the same period. These effects may be more pronounced in funds with larger or inverse multiples and in funds with volatile benchmarks. Investors should monitor their Geared ProShares holdings consistent with their strategies, as frequently as daily. For more on correlation, leverage and other risks, please read the prospectus.

Investing involves risk, including the possible loss of principal. These ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Short ProShares should lose money when their benchmarks or indexes rise. Technology companies may be subject to severe competition and product obsolescence. Investments in smaller companies typically exhibit higher volatility. Smaller company stocks also may trade at greater spreads or lower trading volumes, and may be less liquid than stocks of larger companies. Narrowly focused investments typically exhibit higher volatility. Please see their summary and full prospectuses for a more complete description of risks. Obtain them from your financial advisor or broker-dealer representative or visit ProShares.com. There is no guarantee any ProShares ETF will achieve its investment objective.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "NASDAQ Biotechnology Index^®" is a trademark of The NASDAQ OMX Group, Inc. The “Dow Jones U.S. Select Home Construction Index” and the “S&P Oil & Gas Exploration & Production Select Industry Index” are products of S&P Dow Jones Indices LLC and its affiliates. "S&P^®" is a registered trademark of Standard & Poor's Financial Services LLC ("S&P") and "Dow Jones^®" is a registered trademark of Dow Jones Trademark Holdings LLC ("Dow Jones") and have been licensed for use by S&P Dow Jones Indices LLC and its affiliates. All have been licensed for use by ProShares. ProShares have not been passed on by these entities or their subsidiaries or affiliates as to their legality or suitability. ProShares are not sponsored, endorsed, sold or promoted by these entities or their subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THESE ENTITIES AND THEIR SUBSIDIARIES AND AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds' advisor.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150623005850/en/